Delivery Order SPE2DX22D0059-SPE2D825F0JHT
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $60,131.30 from the Defense Logistics Agency's Medical Supply Chain on August 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $3,798.36 from the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. This firm fixed-price contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,910.72 delivery order contract by the Defense Logistics Agency's Medical Supply Chain on August 13, 2025. This firm fixed-price, competitively awarded contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $22,869.00 by the Defense Logistics Agency's Medical Supply Chain on August 16, 2025. This firm fixed-price, non-set-aside contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,340.40 by the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $8,301.00 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025. This non-set-aside contract represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order is scheduled for ultimate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $17,207.80 on August 16, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is scheduled for completion by August 18, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,594.95 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with completion targeted for August 19, 2025. This firm fixed-price delivery order represents a child contract issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,991.18 by the Defense Logistics Agency Medical Supply Chain on July 26, 2025. The contract, designated as a firm fixed price delivery order with no set-aside provisions, represents a child award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $37,470.85 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This firm fixed-price contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is non-competitive and scheduled for ultimate...
- SPE2DX22D0059Indefinite Delivery Contract
- SPE2DX22D0059-SPE2D825F0JHTDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has received a delivery order valued at $8,302.51 from the Defense Logistics Agency's Medical Supply Chain division. Issued on August 11, 2025, this firm fixed-price contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance. This delivery order exemplifies AmerisourceBergen Drug Corp's role as a critical pharmaceutical supplier to federal military and healthcare systems. The company's comprehensive federal procurement portfolio includes a wide range of pharmaceutical products and medical supplies—including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities—delivered through the broader Global Pharmaceutical Prime Vendor program. The delivery order is scheduled for ultimate completion by August 12, 2025, supporting the Defense Logistics Agency's mission to supply pharmaceutical products and medical materials to Defense Health Agency operations, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 8/11/25 |